Coronavirus Limits Access to Addiction Treatment
The coronavirus is limiting access to treatment options addicts desperately need.
The coronavirus is limiting access to treatment options addicts desperately need.
Pharmacies want physicians to be held accountable for prescribing addictive opioids.
A new NEJM study suggests supervised injection is a valid addiction treatment option.
Drug development company is determined, despite second rejection, to get pain management drug approved.
Leptin may be a safer pain management option for patients with sleep apnea in trauma centers, according to new study.
Canada’s authorities warn that carfentanil, a powerful opioid, has been found in at least one overdose case.
Shaun Thaxter charged with misbranding Suboxone Film.
Spokane’s Excelsior will treat minors for substance use disorder and mental illness under Ricky’s Law.
A new Penn Medicine study published in JAMA Cardiology found “10% of heart surgery patients who were prescribed opioid medications were still taking them more than 90 days after their procedures” and researchers “found a direct association between the initial dosing of opioids or oral morphine equivalents and the likelihood of persistent use 90 to
Opioid treatment center met with ‘not in my backyard’ opposition.